Invention Grant
- Patent Title: N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
-
Application No.: US10291318Application Date: 2002-11-08
-
Publication No.: US07176242B2Publication Date: 2007-02-13
- Inventor: Varghese John , Michel Maillard , Barbara Jagodzinska , James Beck , Andrea Gailunas , John Freskos , John Mickelson , Lakshman Samala , Jennifer Sealy , Ruth TenBrink , Lawrence Fang , Roy Hom
- Applicant: Varghese John , Michel Maillard , Barbara Jagodzinska , James Beck , Andrea Gailunas , John Freskos , John Mickelson , Lakshman Samala , Jennifer Sealy , Ruth TenBrink , Lawrence Fang , Roy Hom
- Applicant Address: US CA So. San Francisco US MI Kalamazoo
- Assignee: Elan Pharmaceuticals, Inc.,Pharmacia & Upjohn Company
- Current Assignee: Elan Pharmaceuticals, Inc.,Pharmacia & Upjohn Company
- Current Assignee Address: US CA So. San Francisco US MI Kalamazoo
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: A61K31/133
- IPC: A61K31/133 ; C07C217/00
Abstract:
Disclosed are compounds of the formula wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.
Public/Granted literature
- US20040171881A1 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives Public/Granted day:2004-09-02
Information query
